Date: August 19th-22nd
Location: Booth 312, Sheraton Boston + Virtual, Boston
We eagerly anticipate connecting with you at the Bioprocessing Summit, where thought leaders and pioneers in bioprocess R&D, scale-up, quality, and analytics are brought together. Join us at Booth 312.
Explore how our microfluidic picodroplet technology platforms can accelerate your workflows, from Cell Line Development to other applications. Let’s discuss how we can streamline your processes and enhance efficiency.
Learn more about Picodroplets at our Poster Presentation - Poster Session A (19th August and 20th August)
Simona Preiksaite will be presenting
Title:
Picodroplets for Biologics Discovery and Cell Line Development: Accelerating the Discovery and Development Process
Description:
Although antibody therapeutics dominate drug development, prolonged workflows and increasing costs during their discovery and development hinder their success. Cyto-Mine® by Sphere Fluidics, utilizes picodroplet technology, microfluidics and imaging, to address these obstacles in Antibody Discovery (AbD) and Cell Line Development (CLD), expediting therapeutic development.
Cyto-Mine® offers significant advantages in the number of cells that can be processed, cost per run, and the speed with which projects can be completed. Sphere Fluidics has developed a 2nd generation Cyto-Mine® instrument that enables the use of more fluors, multiplexed assays, and a broader range of applications.
Early applications of the new Cyto-Mine® platform will enable cell isolation based on cell surface markers, viability, and titer of secreted proteins. Moreover, in combination with re-injection-based workflows, it will facilitate complex assays like combining cell types in a single droplet (crucial for binding assessment, cytotoxic assays, and advancing antibody development).
Location, Date & Time:
Poster #TBC, Poster Session A (19th August [17:30-18.30] and 20th August [10:00-10:45, 13:30-14:10, and 15:45-16:30])
